Skip to main content
TipRanks
Go Ultimate75% OFF

Alzamend Neuro (9ZT) Stock Price & Analysis

2 Followers

9ZT Stock Chart & Stats

€194.40€0.00(0.00%)
At close: 5:30 PM GMT+1
€1K€1.5KSep 20May 25
Day’s Range
EUR 194.40 - EUR 194.40
52-Week Range
EUR 194.40 - EUR 194.40
Previous Close
EUR 194.40
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 5.18M
Enterprise Value
EUR 1.21T
Total Cash (Recent Filing)
EUR 7.59M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
0.00
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Alzamend Neuro News

9ZT FAQ

What was Alzamend Neuro’s price range in the past 12 months?
Alzamend Neuro lowest stock price was €194.40 and its highest was €194.40 in the past 12 months.
What is Alzamend Neuro’s market cap?
Alzamend Neuro’s market cap is €5.18M.
When is Alzamend Neuro’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alzamend Neuro’s earnings last quarter?
Alzamend Neuro released its earnings results on Mar 16, 2023. The company reported -€70.971 earnings per share for the quarter, missing the consensus estimate of -€47.314 by -€23.657.
Is Alzamend Neuro overvalued?
According to Wall Street analysts Alzamend Neuro’s price is currently Overvalued.
Does Alzamend Neuro pay dividends?
Alzamend Neuro does not currently pay dividends.
What is Alzamend Neuro’s EPS estimate?
Alzamend Neuro’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzamend Neuro have?
Alzamend Neuro has 4,825,723 shares outstanding.
What happened to Alzamend Neuro’s price movement after its last earnings report?
Alzamend Neuro reported an EPS of -€70.971 in its last earnings report, missing expectations of -€47.314. Following the earnings report the stock price went down -3.224%.
Which hedge fund is a major shareholder of Alzamend Neuro?
Currently, no hedge funds are holding shares in DE:9ZT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology